Tanshinone IIA increases mRNA expression of efflux transporters in cultured human intestinal cell

American Journal of Chinese Medicine

Volumn 38, Issue 5, 2010, Pages 995-1004

  Yin, Ying ^a,b   Yang, Min ^a   Wang, Yanhui ^a   Liu, Xuan ^a   Wu, Wanying ^a   Guan, Shuhong ^a   Guo, De An ^a   Cui, Yajun ^b   Jiang, Baohong ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Bioavailability; Caco 2 Cell; Tanshinone IIA; Transporter

Indexed keywords

MESSENGER RNA; TANSHINONE IIA;

ARTICLE; CELL CULTURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOLOGICAL AVAILABILITY; CACO-2 CELLS; CELLS, CULTURED; COLON; DRUGS, CHINESE HERBAL; HUMANS; INTESTINAL ABSORPTION; MEMBRANE TRANSPORT PROTEINS; PHENANTHRENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALVIA MILTIORRHIZA; UP-REGULATION;

EID: 77956450390     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X1000841X     Document Type: Article

References (33)

1. Arimori, K. and M. Nakano. Drug exsorption from blood into the gastrointestinal tract. Pharm. Res. 15: 371-376, 1998.
2. Artursson, P. and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175: 880-885, 1991.
3. Bellarosa, C., G. Bortolussi and C. Tiribelli. The role of ABC transporters in protecting cells from bilirubin toxicity. Curr. Pharm. Des. 15: 2884-2892, 2009.
4. Chang, C., S. Ekins, P. Bahadduri and P.W. Swaan. Pharmacophore-based discovery of ligands for drug transporters. Adv. Drug Deliv. Rev. 58: 1431-1450, 2006.
5. Cheng, K.C., C. Li and A.S. Uss. Prediction of oral drug absorption in humans-from cultured cell lines and experimental animals. Expert Opin. Drug Metab. Toxicol. 4: 581-590, 2008.
6. Dean, M. ABC transporters, drug resistance, and cancer stem cells. J. Mammary Gland Biol. Neoplasia 14: 3-9, 2009.
7. Elsharkawy, A.M., F. Oakley and D.A. Mann. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10: 927-939, 2005.
8. Enoki, T., Y. Yoshida, J. Lally, H. Hatta and A. Bonen. Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle. J. Physiol. 577: 433-443, 2006.
9. Hosoya, K., T. Kondo, M. Tomi, H. Takanaga, S. Ohtsuki and T. Terasaki. MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina. Pharm. Res. 18: 1669-1676, 2001.
10. Ingels, F.M. and P.F. Augustijns. Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. J. Pharm. Sci. 92: 1545-1558, 2003.
11. Jiang, B., L. Zhang, Y. Wang, M. Li, W. Wu, S. Guan, X. Liu, M. Yang, J. Wang and D.A. Guo. Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vitro. Food Chem. Toxicol. 47: 1538-1544, 2009.
12. Kiuchi, Y., H. Suzuki, T. Hirohashi, C.A. Tyson and Y. Sugiyama. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett. 433: 149-152, 1998.
13. Konig, J., M. Hartel, A.T. Nies, M.E. Martignoni, J. Guo, M.W. Buchler, H. Friess and D. Keppler. Expression and localization of human multidrugy resistance protein (ABCC) family members in pancreatic carcinoma. Int. J. Cancer 115: 359-367, 2005.
14. Lennernas, H. Intestinal permeability and its relevance for absorption and elimination. Xenobiotica 37: 1015-1051, 2007.
15. Ling, W., L.C. Rui and J.X. Hua. In situ intestinal absorption behaviors of Tanshinone IIA from its inclusion complex with hydroxypropyl-beta- cyclodextrin. Biol. Pharm. Bull. 30: 1918-1922, 2007.
16. Lu, T., J. Yang, X. Gao, P. Chen, F. Du, Y. Sun, F. Wang, F. Xu, H. Shang, Y. Huang, Y. Wang, R. Wan, C. Liu, B. Zhang and C. Li. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab. Dispos. 36: 1578-1586, 2008.
17. Meunier, V., M. Bourrié, Y. Berger and G. Fabre. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol. Toxicol. 11: 187-194, 1995.
18. Nicolazzo, J.A. and K. Katneni. Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2). Curr. Top. Med. Chem. 9: 130-147, 2009.
19. Oostendorp, R.L., J.H. Beijnen and J.H. Schellens. The biological and clinical role of drug transporters at the intestinal barrier. Cancer Treat. Rev. 35: 137-147, 2009.
20. Pos, K.M. Drug transport mechanism of the AcrB efflux pump. Biochim. Biophys. Acta 1794: 782-793, 2009.
21. Press, B. and D. Di Grandi. Permeability for intestinal absorption: Caco-2 assay and related issues. Curr. Drug Metab. 9: 893-900, 2008.
22. Russel, F.G., J.B. Koenderink and R. Masereeuw. Multidrug resistance protein 4 (MRP4/ ABCC4): a versatile efflux transporter for drugs and signaling molecules. Trends Pharmacol. Sci. 29: 200-207, 2008.
23. Sarkadi, B., C. Ozvegy-Laczka, K. Nemet and A. Varadi. ABCG2-a transporter for all seasons. FEBS Lett. 567: 116-120, 2004.
24. Seeger, M.A. and H.W. van Veen. Molecular basis of multidrug transport by ABC transporters. Biochim. Biophys. Acta 1794: 725-737, 2009.
25. Staud, F. and P. Pavek. Breast cancer resistance protein (BCRP/ABCG2). Int. J. Biochem. Cell Biol. 37: 720-725, 2005.
26. Stefkova, J., R. Poledne and J.A. Hubacek. ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol. Res. 53: 235-243, 2004.
27. Sun, B., Y. Yuan, W. Zhang and D. Che. Effects of hypoxic endothelial cell conditioned medium on proliferation and collagen synthesis of smooth muscle cells and inhibitory effects of radix salviae miltiorrhizae. Chin. Med. J. 108: 855-858, 1995.
28. Teodori, E., S. Dei, C. Martelli, S. Scapecchi and F. Gualtieri. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR). Curr. Drug Targets 7: 893-909, 2006.
29. Vetvicka, V. and L. Fornusek. Limitations of transmembrane transport in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 5: 141-170, 1988.
30. Xu, L., I.S. Haworth, A.A. Kulkarni. M.B. Bolger and D.L. Davies. Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter. Pharm. Res. 26: 2358-2366, 2009.
31. Yu, X.Q., C.C. Xue, G. Wang and S.F. Zhou. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. Curr. Drug Metab. 8: 787-802, 2007.
32. Zhou, S.F., L.L. Wang, Y.M. Di, C.C. Xue, W. Duan, C.G. Li and Y. Li. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr. Med. Chem. 15: 1981-2039, 2008.
33. Zimmermann, C., H. Gutmann, P. Hruz, J.P. Gutzwiller, C. Beglinger and J. Drewe. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab. Dispos. 33: 219-224, 2005.